Suvretta Capital Management, LLC has filed its 13F form on August 14, 2025 for Q2 2025 where it was disclosed a total value porftolio of $2.91 Billion distributed in 98 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Arcutis Biotherapeutics, Inc. with a value of $162M, 89bio, Inc. with a value of $140M, Legend Biotech Corp with a value of $134M, Meta Platforms, Inc. with a value of $125M, and Coca Cola CO with a value of $87.3M.

Examining the 13F form we can see an increase of $624M in the current position value, from $2.28B to 2.91B.

Suvretta Capital Management, LLC is based out at New York, NY

Below you can find more details about Suvretta Capital Management, LLC portfolio as well as his latest detailed transactions.

Portfolio value $2.91 Billion
Healthcare: $1.26 Billion
ETFs: $584 Million
Technology: $406 Million
Consumer Cyclical: $187 Million
Financial Services: $163 Million
Communication Services: $141 Million
Consumer Defensive: $87.3 Million
Industrials: $80.7 Million
Other: $967,000

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 98
  • Current Value $2.91 Billion
  • Prior Value $2.28 Billion
  • Filing
  • Period Q2 2025
  • Filing Date August 14, 2025
  • Form Type 13F-HR
  • Activity in Q2 2025
  • New Purchases 10 stocks
  • Additional Purchases 29 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 18 stocks
Track This Portfolio

Track Suvretta Capital Management, LLC Portfolio

Follow Suvretta Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Suvretta Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Suvretta Capital Management, LLC with notifications on news.